[July 07, 2011]

Shire CEO Angus Russell to Deliver Keynote Address at Fourth Annual BioPharm America™ Partnering Conference

EBD Group and MassBio today announced that Angus Russell, CEO of Shire, will be the keynote speaker at BioPharm America™, being held in Boston at the Westin Waterfront, September 7-9, 2011. With more than 1,000 dealmakers expected, the 2011 edition of BioPharm America promises to be one of the most productive partnering events of the year for the biotech industry.

"Partnering is a central strategy for success in today's biotech industry, and as the industry continues to shift around personalized medicine, establishing the right partnerships is more important than ever," said Russell. "BioPharm America 2011 provides an exceptional opportunity for companies representing the biotech industry value chain to identify new opportunities, and start the conversations that lead to tomorrow's partnerships and acquisitions."

A highly regarded leader in the life science industry, Russell has been CEO of Shire since 2008 and has been a member of the board since 1999. He was the company's CFO from December 1999 to June 2008, and is also the chairman of the company's leadership team. Between 1980 and 1999, he held a number of positions of increasing responsibility at ICI, Zeneca and AstraZeneca PLC, including VP, Corporate Finance at AstraZeneca and Group Treasurer at Zeneca.

"We're honored to have Angus Russell sharing his insights at BioPharm America," said Carola Schropp, President of EBD Group, organizers of the conference. "This year's edition is attracting a notable group of large pharma, innovative development stage companies and leading financiers, and again will turn Boston into the hub of life science dealmaking."

Robert K. Coughlin, President and CEO of the event's host organization, MassBio, added, "More and more, collaboration between pharma, biotech, venture and academia proves to be the model for moving innovation out of the lab and into the market. BioPharm America continues to be a venue where those collaborations begin."

About MassBio

MassBio, a not-for-profit organization that represents and provides services and support for the Massachusetts biotechnology industry, is the nation's oldest biotechnology trade associatin. Founded in 1985, MassBio is committed to advancing the development of critical new science, technology and medicines that benefit people worldwide. Representing over 600 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, MassBio works to advance policy and promote education, while providing member programs and events, industry information, and services.

For more information please visit www.massbio.org.

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group's conferences are run with the support of leading corporations and international trade associations and include:

• BIO-Europe® and BIO-Europe Spring®, the world's largest stand-alone life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
• BioPharm America™, the fastest growing partnering event in North America
• EuroMedtech™, EBD Group's partnering event for the innovative medical technology industry
• BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
• ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
• Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors

EBD Group's sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world.

Outside of the conference format, EBD Group's consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies.

EBD Group has offices in the USA and Europe.

For more information please visit www.ebdgroup.com.

[ Back To SIP Trunking Home's Homepage ]